Anhui Heryi Pharmaceutical Co (BJSE:430478) COGS-to-Revenue : 0.64 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Anhui Heryi Pharmaceutical Co COGS-to-Revenue?

Anhui Heryi Pharmaceutical Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥44.7 Mil. Its Revenue for the three months ended in Mar. 2024 was ¥70.0 Mil.

Anhui Heryi Pharmaceutical Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.64.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Anhui Heryi Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2024 was 36.19%.

Anhui Heryi Pharmaceutical Co COGS-to-Revenue Historical Data

The historical data trend for Anhui Heryi Pharmaceutical Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Heryi Pharmaceutical Co COGS-to-Revenue Chart

Anhui Heryi Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.57

0.55

0.67

0.63

0.64

Anhui Heryi Pharmaceutical Co Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.62	0.65	0.69	0.63	0.64

Anhui Heryi Pharmaceutical Co COGS-to-Revenue Calculation

Anhui Heryi Pharmaceutical Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	144.933	/	226.253
	=	0.64

Anhui Heryi Pharmaceutical Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	44.683	/	70.025
	=	0.64

Anhui Heryi Pharmaceutical Co (BJSE:430478) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Anhui Heryi Pharmaceutical Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	44.683 / 70.025
	=	36.19 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Anhui Heryi Pharmaceutical Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Anhui Heryi Pharmaceutical Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Anhui Heryi Pharmaceutical Co (BJSE:430478) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Heryi Pharmaceutical Co Ltd (BJSE:430478) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

Yangcun Industrial Zone, Anhui Province, Tianchang City, CHN, 239304

Website

http://www.heryipharma.com

Anhui Heryi Pharmaceutical Co Ltd engages in research and development, production, and sales of advanced pharmaceutical intermediates, raw materials, and related products. The main product categories include anti-allergy, anti-thrombosis, anti-oxidation, gastric ulcer, anti-virus, antipyretic and analgesic, and ultraviolet absorbent.

Anhui Heryi Pharmaceutical Co (BJSE:430478) Headlines

No Headlines